Kafka,
With this aquisition, VIRS will add yet another potential AIDS drug to their stable. Remember, AIDS drugs only take 40 days to be reviewed once they are submitted to the FDA. VIRS could have numerous drugs approved by your 2000 date. Also, a 500 million dollar market cap is in line with other biotechs. (look at VRTX, CNTO, IMNX, all have large caps, low revs, and big losses.) Lastly, management has the experience, they come from Burroughs Wellcome, a company that developed AZT. With biotechs, you almost always have to rely on the management.
Tom |
